Morgan Stanley’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24M | Buy |
758,863
+102,759
| +16% | +$3.25M | ﹤0.01% | 2618 |
|
|
2025
Q1 | $21.8M | Sell |
656,104
-150,779
| -19% | -$5M | ﹤0.01% | 2606 |
|
|
2024
Q4 | $27.8M | Sell |
806,883
-43,795
| -5% | -$1.51M | ﹤0.01% | 2426 |
|
|
2024
Q3 | $34M | Buy |
850,678
+14,567
| +2% | +$583K | ﹤0.01% | 2237 |
|
|
2024
Q2 | $25.2M | Sell |
836,111
-49,234
| -6% | -$1.49M | ﹤0.01% | 2411 |
|
|
2024
Q1 | $29.7M | Sell |
885,345
-1,287,085
| -59% | -$43.2M | ﹤0.01% | 2255 |
|
|
2023
Q4 | $70.2M | Buy |
2,172,430
+1,416,985
| +188% | +$45.8M | ﹤0.01% | 2085 |
|
|
2023
Q3 | $24.8M | Buy |
755,445
+25,421
| +3% | +$833K | ﹤0.01% | 2231 |
|
|
2023
Q2 | $25.7M | Buy |
730,024
+167,952
| +30% | +$5.91M | ﹤0.01% | 2211 |
|
|
2023
Q1 | $18.4M | Buy |
562,072
+165,756
| +42% | +$5.41M | ﹤0.01% | 2523 |
|
|
2022
Q4 | $21.8M | Buy |
396,316
+73,534
| +23% | +$4.05M | ﹤0.01% | 2252 |
|
|
2022
Q3 | $14.3M | Buy |
322,782
+109,305
| +51% | +$4.84M | ﹤0.01% | 2577 |
|
|
2022
Q2 | $10.4M | Buy |
213,477
+51,903
| +32% | +$2.53M | ﹤0.01% | 3028 |
|
|
2022
Q1 | $7.86M | Sell |
161,574
-9,533
| -6% | -$464K | ﹤0.01% | 3189 |
|
|
2021
Q4 | $7.3M | Buy |
171,107
+126,623
| +285% | +$5.4M | ﹤0.01% | 3315 |
|
|
2021
Q3 | $1.71M | Sell |
44,484
-84,272
| -65% | -$3.23M | ﹤0.01% | 4693 |
|
|
2021
Q2 | $3.63M | Buy |
128,756
+64,929
| +102% | +$1.83M | ﹤0.01% | 4115 |
|
|
2021
Q1 | $2.11M | Buy |
63,827
+42,961
| +206% | +$1.42M | ﹤0.01% | 4219 |
|
|
2020
Q4 | $755K | Buy |
20,866
+20,816
| +41,632% | +$753K | ﹤0.01% | 4820 |
|
|
2020
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 6571 |
|